Back to R&D

Aaron Boudreau, Ph.D.

Principal Scientist

Aaron works in the Stokoe lab, which uses cancer genomics, combined with phenotypic screening, to identify and validate novel oncology drug targets.

Aaron’s work focuses on identifying, validating, and characterizing new synthetic lethal opportunities in oncology for eventual drug development. Prior to joining Calico, Aaron worked at Genentech supporting several early-stage research programs with an emphasis on tumor metabolism and drug resistance. Before that, he completed a postdoc at the University of California at San Francisco where he developed new strategies to extract highly prognostic and predictive features from transcriptomics data.